Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 0: clinchem.2008.112243v1, 2008; 10.1373/clinchem.2008.112243
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
clinchem.2008.112243v1
54/12/2042    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Eichinger, S.
Right arrow Articles by Kyrle, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Eichinger, S.
Right arrow Articles by Kyrle, P. A.

Received on June 11, 2008
Accepted on August 27, 2008

Hemostasis and Thrombosis

Prediction of Recurrent Venous Thromboembolism by Endogenous Thrombin Potential and D-Dimer

Sabine Eichinger 1*, Gregor Hron 1, Marietta Kollars 1, Paul A. Kyrle 1

1 Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria

* To whom correspondence should be addressed. E-mail: sabine.eichinger{at}meduniwien.ac.at.

BACKGROUND: Increased thrombin generation is associated with an increased risk of recurrent venous thromboembolism. We investigated the relation between endogenous thrombin potential (ETP) and risk of recurrent venous thromboembolism and evaluated whether prediction of recurrence can be improved by a combined analysis of ETP and D-dimer.

METHODS: We followed 861 patients with first spontaneous venous thromboembolism and determined ETP and D-dimer after discontinuation of anticoagulation. Patients with natural inhibitor deficiency, lupus anticoagulant, or cancer were excluded. The study endpoint was symptomatic recurrent venous thromboembolism.

RESULTS: One hundred thirty patients (15.1%) had recurrence. High ETP (≥100%) conferred a 1.6-fold increased risk of recurrence (95% CI 1.1–2.3) after adjustment for age, sex, factor V Leiden, factor II G20210A, and duration of anticoagulation. After adjustment for D-dimer, risk of recurrence remained significantly higher among patients with high ETP [hazard ratio 1.6 (95% CI 1.01–2.4)]. After adjustment for ETP, high D-dimer (≥0.5 mg/L) conferred a 1.8-fold (95% CI 1.1–2.8) increased risk of recurrence. Compared with patients with low ETP and low D-dimer, risk of recurrence increased to 2.8 (95% CI 1.5–5.3) among patients with both high ETP and high D-dimer after adjustment for potential confounders.

CONCLUSIONS: ETP and D-dimer are independent predictors of recurrent venous thromboembolism. Assessing risk of recurrence can be optimized by combining these indicators of thrombin generation.




The following articles in journals at HighWire Press have cited this article:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
I. Pabinger and C. Ay
Biomarkers and Venous Thromboembolism
Arterioscler Thromb Vasc Biol, March 1, 2009; 29(3): 332 - 336.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
T. K. Brock, N. L. Gentile, R. F. Louie, N. K. Tran, T. Kitano, and G. J. Kost
Assessing Thrombin Generation at the Point of Care
Clin. Chem., March 1, 2009; 55(3): 398 - 399.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2008 by the American Association for Clinical Chemistry.